ICU Medical (NASDAQ:ICUI) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

ICU Medical, Inc. (NASDAQ:ICUI) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $157.00 and traded as high as $162.01. ICU Medical shares last traded at $160.99, with a volume of 133,187 shares trading hands.

Analyst Ratings Changes

ICUI has been the topic of several analyst reports. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp lifted their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. Finally, Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $199.67.

ICU Medical Stock Down 4.1 %

The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm has a market cap of $3.78 billion, a P/E ratio of -33.77 and a beta of 0.63. The business has a 50-day moving average price of $163.34 and a 200-day moving average price of $157.00.

Insider Transactions at ICU Medical

In other news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Vivek Jain sold 12,000 shares of the stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $17,973,261.12. The trade was a 10.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 29,737 shares of company stock valued at $4,941,832 in the last quarter. 6.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Rhumbline Advisers boosted its position in shares of ICU Medical by 23.0% during the second quarter. Rhumbline Advisers now owns 66,916 shares of the medical instruments supplier’s stock worth $7,946,000 after buying an additional 12,519 shares during the period. Victory Capital Management Inc. lifted its stake in ICU Medical by 2,966.3% in the second quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock worth $16,844,000 after acquiring an additional 137,222 shares during the last quarter. Arizona State Retirement System lifted its position in shares of ICU Medical by 7.9% during the 2nd quarter. Arizona State Retirement System now owns 6,082 shares of the medical instruments supplier’s stock worth $722,000 after purchasing an additional 443 shares during the last quarter. Savant Capital LLC purchased a new position in shares of ICU Medical in the 2nd quarter valued at about $431,000. Finally, Choreo LLC acquired a new stake in ICU Medical during the second quarter worth approximately $313,000. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.